Influence of European Market Dynamics on Biosimilars Market Share

Introduction: Innovative biologic medicines have been linked to a skyrocketing cost which introduces high pressures on the already constrained national health budgets. The adoption of biosimilars (similar versions of an approved biologic reference product) allows to expand patients’ access to costly...

Full description

Bibliographic Details
Main Authors: Diogo Pires, João Gonçalves
Format: Article
Language:English
Published: Formifarma, LDA. 2016-10-01
Series:Revista Portuguesa de Farmacoterapia
Subjects:
Online Access:http://revista.farmacoterapia.pt/index.php/rpf/article/view/130